Search results
7 lip 2021 · First, studies of the lifetime costs of HIV treatment should provide more details on major cost components to allow for comparisons across studies. We commend the authors’ attempt to present these details in their supplementary table.
View cost considerations and cost-effectiveness of antiretroviral therapy use in adults and adolescents with HIV.
A 2021 systematic review of global estimates for lifetime costs of managing HIV found that the median lifetime cost in high-income countries was £296,022* and estimates ranged from £85,861- £726,640*.
9 sie 2023 · The indicator to be reported is total and subtotal HIV expenditures by services or programme categories and by financing sources. There are eight core sub-indicators that map to this reporting. These are outlined under Annex 3.
29 kwi 2019 · Box plot showing the median, interquartile range, and outlier per person annual antiretroviral therapy (ART) cost for each of the 36 subcohorts as recorded in the HIV and AIDS Reporting System (HARS) (n = 68 801). Each subcohort represents a different year since diagnosis.
1 lip 2021 · The median lifetime costs for managing HIV differed according to: country income level: $5221 [interquartile range (IQR)]: 2978–11 177) for low-income to $377 820 (IQR: 260 176–541 430) for high-income; study perspective: $189 230 (IQR: 14 794–424 069) for healthcare provider, to $508 804 (IQR: 174 781–812 418) for societal; and ...
20 mar 2021 · List prices of first-line ART regimens for most people with HIV range from US$23 000 to $39 000 annually (wholesale acquisition cost [WAC]) and have nearly doubled in price over the past decade. 18,19 As consolidated two-drug regimens (eg, dolutegravir–lamivudine), medications with unique administration routes (eg, injectables or implants), and ...
